NFKB1 and endometriosis: The lipid active ingredient glycyrrhizic acid inhibits activation of the NF-κB signaling pathway, modulates immune cells at the maternal-fetal interface, attenuates endometrial pyroptosis and inflammation during pregnancy (106, 107), and significantly inhibits the development of endometriosis (108).